Executive Director, Global Medical Affairs Companion Diagnostic Lead

About the role

This senior leadership role will shape and execute global medical affairs strategies for companion diagnostics (CDx) supporting oncology programs. You will work across Global Medical Affairs, Clinical Development, Commercial, Biometrics, Clinical Operations, and Translational Research. The position offers the opportunity to influence CDx strategy from clinical development through launch and post-launch evidence generation. You will lead evidence-generation initiatives, including clinical and real-world studies, while helping optimize diagnostic adoption and utilization. The role also involves engaging leading oncologists and pathologists to inform strategy, address barriers, and identify future evidence needs. As a global cross-functional leader, you will contribute to launch readiness, scientific communications, training, publications, and external partnerships. The position is remote within the United States, with approximately 25% travel and substantial collaboration across global teams.

Responsibilities

• Develop and execute a global Medical Affairs strategy for companion diagnostics, aligning it with broader medical and clinical development strategies.
• Lead cross-functional planning for successful CDx development, launch readiness, and ongoing program execution.
• Generate and oversee clinical and real-world evidence, including investigator-initiated studies, testing-utilization studies, diagnostic accuracy studies, and clinical utility studies.
• Partner closely with disease-area medical leads to integrate CDx strategies into broader medical strategies.
• Lead data-generation activities involving laboratory-developed tests (LDTs) and follow-on CDx testing, ensuring alignment with global strategy.
• Provide global and regional insights on pipeline programs requiring companion diagnostics and help inform future development strategies.
• Establish and maintain relationships with key opinion leaders in oncology and pathology to support CDx strategy, launch preparation, evidence generation, and utilization.
• Collaborate with Commercial and other functions to support market-launch readiness and ensure alignment across CDx activities.
• Gather external expert feedback on barriers to CDx adoption and opportunities to optimize testing and companion-drug utilization.
• Identify and validate future evidence-generation priorities through engagement with oncologists, pathologists, and other experts.
• Develop and deliver appropriate CDx training for medical and field teams.
• Support scientific publications and provide medical review of diagnostic materials and communications.
• Represent Global Medical Affairs in relevant alliance partnerships when appropriate.
• Establish, track, execute, and report against program goals, objectives, budgets, timelines, and deliverables.
• Support budget planning and management while maintaining compliant business practices.
• Contribute to the development and implementation of relevant standard operating procedures and policies.

Requirements

• Advanced scientific or medical degree such as MD, PharmD, PhD, or equivalent, with subspecialty training in oncology.
• Extensive pharmaceutical or biotechnology experience in solid tumors, including at least 8 years of relevant industry experience.
• Clinical experience in solid-tumor oncology combined with prior companion diagnostic medical